Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32)-Reference-Cited by-同舟云学术

Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32)

Published:1992-02 Issue:4 Volume:43 Page:865-872
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chuang Linda F.,Kung Hsiang-Fu,Israel Mervyn,Chuang Ronald Y.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference33 articles.

1. The anthracycline antibiotics: New directions in drug development and cancer treatment;Muggia,1983

2. Anthracyclines;Myers,1982

3. N-Trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than Adriamycin;Israel;Cancer Res,1975

4. Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladrianiycin-14-valerate;Vecchi;Cancer Treat Rep,1978

5. N-Tri-fluoroacetyladriamycin-14-valerate: Additional mouse antitumor and toxicity studies;Parker;Cancer Treat Rep,1978

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying eleven new ferroptosis inhibitors as neuroprotective agents from FDA-approved drugs;Bioorganic Chemistry;2024-05

2. Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates;Current Topics in Medicinal Chemistry;2011-06-01

3. Expeditious synthesis of N-bridged heterocycles via dipolar cycloaddition of pentafulvenes with 3-oxidopyridinium betaines;Tetrahedron;2011-02

4. Topical application of valrubicin has a beneficial effect on developing skin tumors;Carcinogenesis;2010-06-16

5. Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model;Journal of Investigative Dermatology;2010-02